Eli Lilly and Company

Advisor/Sr. Advisor - Global Quality Control - Deviation Mentor

Indianapolis, Indiana, United States

$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
InternshipJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must hold a Bachelor’s or Master’s degree in Chemistry, Biology, Engineering, or a related scientific field, and possess a minimum of 5 years of experience in the pharmaceutical or biotechnology industry. They should demonstrate expertise in leading complex root cause investigations, along with experience in cross-functional teamwork and leadership.

Responsibilities

The Global Quality Control - Deviation Mentor will develop and deliver training programs related to deviation investigations and root cause analysis, mentor and advise investigators at new QC sites, guide reviewers and approvers in investigation quality, assist with complex investigations, serve as a technical reviewer and approver for investigations, participate in deviation and change control review boards, evaluate the quality of approved investigations, coach analysts and technical leads, contribute to site metrics and dashboards, support continuous improvement initiatives, prepare staff for inspection interactions, and integrate global deviation management initiatives into site-level quality practices.

Skills

Root Cause Analysis
Deviation Investigations
Training Development
Mentoring
Leadership
Cross-functional Teamwork
Technical Review
Approvals
Quality Assurance
Pharmaceutical Industry
Biotechnology Industry

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI